Büyüklü M.2024-06-122024-06-1220071302-8723https://hdl.handle.net/20.500.14551/17500[No abstract available]trinfo:eu-repo/semantics/closedAccessAcetylsalicylic Acid; Dipeptidyl Carboxypeptidase Inhibitor; Hemoglobin; Novel Erythropoiesis Stimulating Protein; Recombinant Erythropoietin; Tumor Necrosis Factor Alpha; Erythropoietin; Anemia; Angiogenesis; Blood Transfusion; Cardiovascular Risk; Glomerulus Filtration Rate; Heart Failure; Hemoglobin Determination; Human; Letter; Plasma Volume; Thrombosis; Anemia; Female; Heart Failure; Hospitalization; Male; Pathology; Anemia; Erythropoietin; Female; Heart Failure; Humans; Male; Severity Of Illness IndexHeart failure: Erythropoietin in treatment of anemia [18]Kalp yetersizligi: Anemi tedavisinde eritropoetinLetter733423432-s2.0-3464881718017785241N/A